Welcome and Congress Overview
Keynote Lecture: Success and Challenges of Cord Blood Transplant
FDA’s Approach to the Regulation of Regenerative Medicine Products
Cord Blood-Derived Exosome-Based Therapies
Overcoming Collection Obstacles: Public and Family Banking Perspectives
Placental MSC To Reverse Aging
Treatment of Childhood Cerebral Palsy with Cord Blood
Specification Requirements for Releasing Cellular Therapeutic Products for Clinical Application
Original Pioneers
21st Century Cures Act Impact on Cord Blood and Cord Tissues
Manufacturing MSC from Marrow: Role of Culture Rescue
Continued Funding of Public Cord Blood in the United Kingdom
Optimizing Cord Blood Collection with the Resurgence of Delayed Cord Clamping
Collecting High Volume Units – Tricks and Tools
New Standards and Tools for Cord Blood and Perinatal Tissues under the EU-ATMP Regulation
Current FDA Guidance Relative to Homologous Use in HPC and Regenerative Therapies
Public Cord Blood as a Desirable Graft Source
Overview of Cord Blood-Derived Immunotherapies
T-Regs
Bone Marrow MSC To Treat Adult Frailty
Biopreservation Best Practices for Cells and Tissues
Excellent Outcomes after Umbilical Cord Blood Transplantation Using a Centralized Cord Blood Registry
Noninvasive, Fast and Cost-Effective Qualification of Blood Collection Bags
Toward a Sustainable Cord Blood Supply in the United States
Influence of Microbiome on Hematopoietic Cell Therapy Outcomes
Next Generation Conditioning Regimens: Reduced Toxicity without Increased Risk of Relapse
Outcome Data in the Research Environment
Fucosylation
Homing and Ex-Vivo Expansion
Panel Discussion on Homing and Ex-Vivo Expansion.
The Use of Umbilical Cord Tissue for Isolating CL-MSC in Treatment for Diabetic Foot Ulcers
Pediatric AML Donor Comparison or Immune Reconstitution
Considering the “What Ifs”
Evolving Ethical Considerations in Regenerative Medicine
This presentation is not available, by agreement with the author.
Evolving Ethical Considerations in Regenerative Medicine
This presentation is not available, by agreement with the author.
Manufacturing MSC from Allogeneic Cord Tissue
This presentation is not available, by agreement with the author.
Manufacturing MSC from Allogeneic Cord Tissue
This presentation is not available, by agreement with the author.
Characterization and Variability of MSCs from Multiple Tissue Sources – A Consortium Approach
This presentation is not available, by agreement with the author.
Characterization and Variability of MSCs from Multiple Tissue Sources – A Consortium Approach
This presentation is not available, by agreement with the author.
Cord Blood-Derived Virus-Specific T-Cells
This presentation is not available, by agreement with the author.
Cord Blood-Derived Virus-Specific T-Cells
This presentation is not available, by agreement with the author.
Treatment of Childhood Autism with Cord Tissue MSCs
This presentation is not available, by agreement with the author.
Treatment of Childhood Autism with Cord Tissue MSCs
This presentation is not available, by agreement with the author.
Microbial Contamination in Umbilical Cord Blood: A Comparison Before and After Cryopreservation
This presentation is not available, by agreement with the author.
Microbial Contamination in Umbilical Cord Blood: A Comparison Before and After Cryopreservation
This presentation is not available, by agreement with the author.
Cord Blood-Derived NK-CAR Cells for Treatment of Cancer
This presentation is not available, by agreement with the author.
Cord Blood-Derived NK-CAR Cells for Treatment of Cancer
This presentation is not available, by agreement with the author.
Post-HCT Viral Infections: Prophylaxis in Cord Blood Transplant Patients
This presentation is not available, by agreement with the author.
Post-HCT Viral Infections: Prophylaxis in Cord Blood Transplant Patients
This presentation is not available, by agreement with the author.
NICORD Ex-Vivo Expansion
This presentation is not available, by agreement with the author.
Magenta
This presentation is not available, by agreement with the author.
Nohla
This presentation is not available, by agreement with the author.
ExcellThera
This presentation is not available, by agreement with the author.
Feasibility and Reimbursement: FDA Approved Therapy Lessons
This presentation is not available, by agreement with the author.
Feasibility and Reimbursement: FDA Approved Therapy Lessons
This presentation is not available, by agreement with the author.